Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade (Q36122631)

12 August 2017

1 reference

title

Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade (English)

1 reference

12 August 2017

Allen SD

1 reference

12 August 2017

Rawale SV

series ordinal

1 reference

12 August 2017

Whitacre CC

series ordinal

1 reference

12 August 2017

Kaumaya PT

series ordinal

1 reference

12 August 2017

publication date

1 June 2005

1 reference

Chemical Biology and Drug Design

12 August 2017

published in

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

page(s)

591-604

1 reference

The CD40/CD40L costimulatory pathway in inflammatory bowel disease

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Boosting T cell costimulation in cancer: the possibilities seem endless

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

T-cell costimulatory pathways in allograft rejection and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Costimulatory regulation of T cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

The roles of the new negative T cell costimulatory pathways in regulating autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

T-cell regulation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

New perspectives of CD28-B7-mediated T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

21 January 2018

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

CTLA-4 can function as a negative regulator of T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

CD28/B7 costimulation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

The interaction properties of costimulatory molecules revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

CTLA-4 and tolerance: the biochemical point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

The CD40 pathway in allograft rejection, acceptance, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

CD40-mediated activation of T cells accelerates, but is not required for, encephalitogenic potential of myelin basic protein-recognizing T cells in a model of progressive experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

CD40/CD154 interactions at the interface of tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Visualization of specific B and T lymphocyte interactions in the lymph node

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

The role of CD40 in the regulation of humoral and cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Immune regulation by CD40 and its ligand GP39.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

CD28-independent costimulation of T cells in alloimmune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

The mosaic of immunosuppressive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

CD40 and its crucial role as a member of the TNFR family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Mimicry of native peptide antigens by the corresponding retro-inverso analogs is dependent on their intrinsic structure and interaction propensities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

The design, synthesis and application of stereochemical and directional peptide isomers: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Ligand recognition by alpha beta T cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

A survey of left-handed polyproline II helices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

CTLA-4 ligation blocks CD28-dependent T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Cutting Edge: Persistent Viral Infection Prevents Tolerance Induction and Escapes Immune Control Following CD28/CD40 Blockade-Based Regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3011.2005.00256.X

10.1111/J.1399-3011.2005.00256.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference